RSPO2 and carcinoma: We further examined the DNA methylation status of RSPO2 in the TCGA-COAD dataset considering the mutational status of patients with APC, KRAS and TP53 mutations (Fig. 6B), which may resemble the temporal acquisition of these mutations in a classical model of the adenoma to carcinoma sequence [24].